Literature DB >> 21757580

Human CRB1-associated retinal degeneration: comparison with the rd8 Crb1-mutant mouse model.

Tomas S Aleman1, Artur V Cideciyan, Geoffrey K Aguirre, Wei Chieh Huang, Cristina L Mullins, Alejandro J Roman, Alexander Sumaroka, Melani B Olivares, Frank F Tsai, Sharon B Schwartz, Luk H Vandenberghe, Maria P Limberis, Edwin M Stone, Peter Bell, James M Wilson, Samuel G Jacobson.   

Abstract

PURPOSE: To investigate the human disease due to CRB1 mutations and compare results with the Crb1-mutant rd8 mouse.
METHODS: Twenty-two patients with CRB1 mutations were studied. Function was assessed with perimetry and electroretinography (ERG) and retinal structure with optical coherence tomography (OCT). Cortical structure and function were quantified with magnetic resonance imaging (MRI). Rd8 mice underwent ERG, OCT, and retinal histopathology.
RESULTS: Visual acuities ranged from 20/25 to light perception. Rod ERGs were not detectable; small cone signals were recordable. By perimetry, small central visual islands were separated by midperipheral scotomas from far temporal peripheral islands. The central islands were cone mediated, whereas the peripheral islands retained some rod function. With OCT, there were small foveal islands of thinned outer nuclear layer (ONL) surrounded by thick delaminated retina with intraretinal hyperreflective lesions. MRI showed structurally normal optic nerves and only subtle changes to occipital lobe white and gray matter. Functional MRI indicated that whole-brain responses from patients were of reduced amplitude and spatial extent compared with those of normal controls. Rd8 mice had essentially normal ERGs; OCT and histopathology showed patchy retinal disorganization with pseudorosettes more pronounced in ventral than in dorsal retina. Photoreceptor degeneration was associated with dysplastic regions.
CONCLUSIONS: CRB1 mutations lead to early-onset severe loss of vision with thickened, disorganized, nonseeing retina. Impaired peripheral vision can persist in late disease stages. Rd8 mice also have a disorganized retina, but there is sufficient photoreceptor integrity to produce largely normal retinal function. Differences between human and mouse diseases will complicate proof-of-concept studies intended to advance treatment initiatives.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21757580      PMCID: PMC3176016          DOI: 10.1167/iovs.11-7701

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  56 in total

1.  The variability of human, BOLD hemodynamic responses.

Authors:  G K Aguirre; E Zarahn; M D'esposito
Journal:  Neuroimage       Date:  1998-11       Impact factor: 6.556

2.  Interocular asymmetry of visual function in heterozygotes of X-linked retinitis pigmentosa.

Authors:  S G Jacobson; K Yagasaki; W J Feuer; A J Román
Journal:  Exp Eye Res       Date:  1989-05       Impact factor: 3.467

3.  Preserved para-arteriole retinal pigment epithelium (PPRPE) in retinitis pigmentosa.

Authors:  J R Heckenlively
Journal:  Br J Ophthalmol       Date:  1982-01       Impact factor: 4.638

4.  Crumbs homolog 1 (CRB1) mutations result in a thick human retina with abnormal lamination.

Authors:  Samuel G Jacobson; Artur V Cideciyan; Tomas S Aleman; Michael J Pianta; Alexander Sumaroka; Sharon B Schwartz; Elaine E Smilko; Ann H Milam; Val C Sheffield; Edwin M Stone
Journal:  Hum Mol Genet       Date:  2003-05-01       Impact factor: 6.150

5.  Augmented rod bipolar cell function in partial receptor loss: an ERG study in P23H rhodopsin transgenic and aging normal rats.

Authors:  T S Aleman; M M LaVail; R Montemayor; G Ying; M M Maguire; A M Laties; S G Jacobson; A V Cideciyan
Journal:  Vision Res       Date:  2001-09       Impact factor: 1.886

6.  Retinal laminar architecture in human retinitis pigmentosa caused by Rhodopsin gene mutations.

Authors:  Tomas S Aleman; Artur V Cideciyan; Alexander Sumaroka; Elizabeth A M Windsor; Waldo Herrera; D Alan White; Shalesh Kaushal; Anjani Naidu; Alejandro J Roman; Sharon B Schwartz; Edwin M Stone; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

7.  Visual acuity in patients with Leber's congenital amaurosis and early childhood-onset retinitis pigmentosa.

Authors:  Saloni Walia; Gerald A Fishman; Samuel G Jacobson; Tomas S Aleman; Robert K Koenekoop; Elias I Traboulsi; Richard G Weleber; Mark E Pennesi; Elise Heon; Arlene Drack; Byron L Lam; Rando Allikmets; Edwin M Stone
Journal:  Ophthalmology       Date:  2010-01-15       Impact factor: 12.079

8.  Electroretinographic analyses of Rpe65-mutant rd12 mice: developing an in vivo bioassay for human gene therapy trials of Leber congenital amaurosis.

Authors:  Alejandro J Roman; Sanford L Boye; Tomas S Aleman; Ji-jing Pang; J Hugh McDowell; Shannon E Boye; Artur V Cideciyan; Samuel G Jacobson; William W Hauswirth
Journal:  Mol Vis       Date:  2007-09-18       Impact factor: 2.367

9.  Alterations of the visual pathways in congenital blindness.

Authors:  Maurice Ptito; Fabien C G Schneider; Olaf B Paulson; Ron Kupers
Journal:  Exp Brain Res       Date:  2008-01-26       Impact factor: 1.972

10.  Targeted disruption of outer limiting membrane junctional proteins (Crb1 and ZO-1) increases integration of transplanted photoreceptor precursors into the adult wild-type and degenerating retina.

Authors:  R A Pearson; A C Barber; E L West; R E MacLaren; Y Duran; J W Bainbridge; J C Sowden; R R Ali
Journal:  Cell Transplant       Date:  2010-01-20       Impact factor: 4.064

View more
  55 in total

1.  Proceedings of the First International Optogenetic Therapies for Vision Symposium.

Authors:  Peter J Francis; Brian Mansfield; Stephen Rose
Journal:  Transl Vis Sci Technol       Date:  2013-11-21       Impact factor: 3.283

2.  The Rd8 mutation of the Crb1 gene is present in vendor lines of C57BL/6N mice and embryonic stem cells, and confounds ocular induced mutant phenotypes.

Authors:  Mary J Mattapallil; Eric F Wawrousek; Chi-Chao Chan; Hui Zhao; Jayeeta Roychoudhury; Thomas A Ferguson; Rachel R Caspi
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-17       Impact factor: 4.799

3.  RPGR-associated retinal degeneration in human X-linked RP and a murine model.

Authors:  Wei Chieh Huang; Alan F Wright; Alejandro J Roman; Artur V Cideciyan; Forbes D Manson; Dina Y Gewaily; Sharon B Schwartz; Sam Sadigh; Maria P Limberis; Peter Bell; James M Wilson; Anand Swaroop; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-08-15       Impact factor: 4.799

4.  Detailed electroretinographic findings in rd8 mice.

Authors:  Alan B Saul; Xuezhi Cui; Shanu Markand; Sylvia B Smith
Journal:  Doc Ophthalmol       Date:  2017-03-27       Impact factor: 2.379

5.  Determining consequences of retinal membrane guanylyl cyclase (RetGC1) deficiency in human Leber congenital amaurosis en route to therapy: residual cone-photoreceptor vision correlates with biochemical properties of the mutants.

Authors:  Samuel G Jacobson; Artur V Cideciyan; Igor V Peshenko; Alexander Sumaroka; Elena V Olshevskaya; Lihui Cao; Sharon B Schwartz; Alejandro J Roman; Melani B Olivares; Sam Sadigh; King-Wai Yau; Elise Heon; Edwin M Stone; Alexander M Dizhoor
Journal:  Hum Mol Genet       Date:  2012-10-03       Impact factor: 6.150

6.  Whole exome sequencing identifies CRB1 defect in an unusual maculopathy phenotype.

Authors:  Stephen H Tsang; Tomas Burke; Maris Oll; Suzanne Yzer; Winston Lee; Yajing Angela Xie; Rando Allikmets
Journal:  Ophthalmology       Date:  2014-05-06       Impact factor: 12.079

7.  Cobalamin C Deficiency Shows a Rapidly Progressing Maculopathy With Severe Photoreceptor and Ganglion Cell Loss.

Authors:  Lucas Bonafede; Can H Ficicioglu; Leona Serrano; Grace Han; Jessica I W Morgan; Monte D Mills; Brian J Forbes; Stefanie L Davidson; Gil Binenbaum; Paige B Kaplan; Charles W Nichols; Patrick Verloo; Bart P Leroy; Albert M Maguire; Tomas S Aleman
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

8.  Nutrient supplementation with n3 polyunsaturated fatty acids, lutein, and zeaxanthin decrease A2E accumulation and VEGF expression in the retinas of Ccl2/Cx3cr1-deficient mice on Crb1rd8 background.

Authors:  Hema L Ramkumar; Jingsheng Tuo; De F Shen; Jun Zhang; Xiaoguang Cao; Emily Y Chew; Chi-Chao Chan
Journal:  J Nutr       Date:  2013-05-15       Impact factor: 4.798

9.  Early degeneration of photoreceptor synapse in Ccl2/Cx3cr1-deficient mice on Crb1(rd8) background.

Authors:  Jun Zhang; Jingsheng Tuo; Xiaoguan Cao; Defen Shen; Wei Li; Chi-Chao Chan
Journal:  Synapse       Date:  2013-05-27       Impact factor: 2.562

10.  AAV-mediated gene therapy in the guanylate cyclase (RetGC1/RetGC2) double knockout mouse model of Leber congenital amaurosis.

Authors:  Sanford L Boye; Igor V Peshenko; Wei Chieh Huang; Seok Hong Min; Issam McDoom; Christine N Kay; Xuan Liu; Frank M Dyka; Thomas C Foster; Yumiko Umino; Sukanya Karan; Samuel G Jacobson; Wolfgang Baehr; Alexander Dizhoor; William W Hauswirth; Shannon E Boye
Journal:  Hum Gene Ther       Date:  2013-02       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.